Insider · CIK 0001905871

Zojwalla Naseem

Reports to the SEC for 1 company · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001905871

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-02	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	CHIEF MEDICAL OFFICER	AAward	+250K sh	—	—	250,000
2026-02-02	OLMAOlema Pharmaceuticals, Inc. · Performance Stock Options (Right to Buy)A Award	CHIEF MEDICAL OFFICER	AAward	+106K sh	—	—	106,250
2025-12-23	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+50K sh	$7.02	+$351K	103,997
2025-12-23	OLMAOlema Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−99.5K sh	$27.66	−$2.75M	4,488
2025-12-23	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−50K sh	—	—	156,818
2025-12-22	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+42.8K sh	$15.25	+$653K	146,815
2025-12-22	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+7,182 sh	$7.02	+$50.4K	153,997
2025-12-22	OLMAOlema Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−100K sh	$28.04	−$2.8M	53,997
2025-12-22	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−42.8K sh	—	—	112,182
2025-12-22	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−7,182 sh	—	—	206,818
2025-12-19	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+40K sh	$15.25	+$610K	173,997
2025-12-19	OLMAOlema Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−57.1K sh	$28.03	−$1.6M	116,918
2025-12-19	OLMAOlema Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−12.9K sh	$28.93	−$374K	103,997
2025-12-19	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−40K sh	—	—	155,000
2025-02-28	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	CHIEF MEDICAL OFFICER	AAward	+205K sh	—	—	205,000
2024-12-16	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+14K sh	$4.87	+$68.2K	129,509
2024-12-16	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−14K sh	—	—	112,840
2024-12-11	OLMAOlema Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−14.2K sh	$8.66	−$123K	115,829
2024-12-11	OLMAOlema Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−320 sh	$9.39	−$3,004.8	115,509
2024-12-10	OLMAOlema Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−13.3K sh	$9.37	−$124K	130,031
2024-12-09	OLMAOlema Pharmaceuticals, Inc.A Award	CHIEF MEDICAL OFFICER	AAward	+52K sh	—	—	143,314
2024-05-24	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+9,460 sh	$4.87	+$46.1K	89,824
2024-05-24	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−9,460 sh	—	—	126,840
2024-03-18	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+13.7K sh	$4.87	+$66.7K	80,364
2024-03-18	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−13.7K sh	—	—	136,300
2024-02-01	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	CHIEF MEDICAL OFFICER	AAward	+195K sh	—	—	195,000
2024-01-25	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+20K sh	$7.02	+$140K	66,664
2024-01-25	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−20K sh	—	—	214,000
2023-12-11	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+2,900 sh	$7.02	+$20.4K	46,664
2023-12-11	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,900 sh	—	—	234,000
2023-12-06	OLMAOlema Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+13.1K sh	$7.02	+$92K	43,764
2023-12-06	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−13.1K sh	—	—	236,900
2023-11-22	OLMAOlema Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−7,095 sh	$13.89	−$98.5K	30,664
2023-11-21	OLMAOlema Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−7,261 sh	$14.83	−$108K	37,959
2023-11-21	OLMAOlema Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−200 sh	$15.33	−$3,066	37,759
2023-11-20	OLMAOlema Pharmaceuticals, Inc.A Award	CHIEF MEDICAL OFFICER	AAward	+28K sh	—	—	45,220
2023-02-01	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	CHIEF MEDICAL OFFICER	AAward	+150K sh	—	—	150,000
2022-02-01	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	CHIEF MEDICAL OFFICER	AAward	+250K sh	—	—	250,000

Recent filings

Accepted (ET)
Feb 44
Zojwalla Naseem0001905871-26-000002
SEC(opens sec.gov)
Dec 234
Zojwalla Naseem0001905871-25-000004
SEC(opens sec.gov)
Mar 34
Zojwalla Naseem0001415889-25-006158
SEC(opens sec.gov)
Dec 174
Zojwalla Naseem0001415889-24-029683
SEC(opens sec.gov)
Dec 114
Zojwalla Naseem0001415889-24-029026
SEC(opens sec.gov)

Companies

Olema Pharmaceuticals, Inc.CHIEF MEDICAL OFFICEROLMA

Address

C/O OLEMA PHARMACEUTICALS, INC. 780 BRANNAN ST

SAN FRANCISCO, CA, 94103